NEW ANGIOTENSIN II RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL: COMPARISON TO VALSARTAN

被引：2
|
作者：
Sica, D. [1 ]
White, W. B. [2 ]
Weber, M. A. [3 ]
Bakris, G. L. [4 ]
Perez, A. [5 ]
Cao, C. [5 ]
Kupfer, S. [5 ]
机构：
[1] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA
[2] Univ Connecticut, Sch Med, Farmington, CT USA
[3] SUNY Downstate Coll Med, New York, NY USA
[4] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[5] Takeda Global Res & Dev, Deerfield, IL USA
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000379014.10568.aa
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E276 / E276
页数：1
相关论文
共 50 条
  • [21] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    G Bönner
    G L Bakris
    D Sica
    M A Weber
    W B White
    A Perez
    C Cao
    A Handley
    S Kupfer
    Journal of Human Hypertension, 2013, 27 : 479 - 486
  • [22] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    Boenner, G.
    Bakris, G. L.
    Sica, D.
    Weber, M. A.
    White, W. B.
    Perez, A.
    Cao, C.
    Handley, A.
    Kupfer, S.
    JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (08) : 479 - 486
  • [23] Effects of high dose angiotensin II receptor blocker - comparison of Valsartan and Candesartan
    Ohishi, Mitsuru
    Ito, Norihisa
    Takagi, Takashi
    Terai, Minako
    Tatara, Yuji
    Shiota, Atsushi
    Hayashi, Norihiro
    Katsuya, Tomohiro
    Rakugi, Hiromi
    Ogihara, Toshio
    JOURNAL OF HYPERTENSION, 2006, 24 : 364 - 364
  • [24] The Novel Angiotensin H Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle
    Lastra, Guido
    Santos, Fernando R.
    Hooshmand, Payam
    Hooshmand, Paria
    Mugerfeld, Irina
    Aroor, Annayya R.
    DeMarco, Vincent G.
    Sowers, James R.
    Henriksen, Erik J.
    CARDIORENAL MEDICINE, 2013, 3 (02) : 154 - 164
  • [25] Dose-response efficacy of valsartan, a new angiotensin II receptor blocker
    Pool, JL
    Glazer, R
    Chiang, YT
    Gatlin, M
    JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (04) : 275 - 281
  • [26] Dose-response efficacy of valsartan, a new angiotensin II receptor blocker
    JL Pool
    R Glazer
    Y-T Chiang
    M Gatlin
    Journal of Human Hypertension, 1999, 13 : 275 - 281
  • [27] EFFICACY AND SAFETY OF THE NOVEL ANGIOTENSIN RECEPTOR BLOCKER, AZILSARTAN-MEDOXOMIL, IN KOREAN PATIENTS WITH ESSENTIAL HYPERTENSION
    Juhasz, Attila
    Wu, Jingtao
    Hisada, Michie
    Tsukada, Tomoka
    Jeong, Myung Ho
    JOURNAL OF HYPERTENSION, 2016, 34 : E84 - E85
  • [28] An Efficient and Telescopic Process for Valsartan, an Angiotensin II Receptor Blocker
    Aalla, Sampath
    Gilla, Goverdhan
    Bojja, Yakambram
    Anumula, Raghupathi Reddy
    Vummenthala, Prabhakar Reddy
    Padi, Pratap Reddy
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (04) : 682 - 686
  • [29] Azilsartan: A next-generation angiotensin II receptor blocker for the treatment of hypertension
    Singh, Pritha
    Fung, Wilson Fung
    Song, Jessica C.
    FORMULARY, 2010, 45 (11) : 342 - 349
  • [30] Angiotensin II receptor blocker-induces blunted taste sensitivity: comparison of candesartan and valsartan
    Tsuruoka, S
    Wakaumi, M
    Ioka, T
    Yamamoto, H
    Ando, H
    Sugimoto, K
    Fujimura, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (02) : 204 - 207
12345